At Reuters Events’ brand-new Cell & Gene Therapy USA virtual conference (November 2, free to attend) experts at Eisai, Brainstorm Cell Therapeutics and Blue Cross Blue Shield of Michigan will unpack the preparations needed to expand to larger patient populations safely and successfully.
By joining this live interactive panel discussion on “Beyond Rare Disease” at Cell & Gene Therapy USA, you will learn about:
- Opportunities for expansion: What is already being done (and opportunities for the industry) to expand the reach of cell and gene therapies beyond rare diseases and small patient populations
- Possible wide-spread impacts: Hear the potential impact commercializing these treatments could have on payer reimbursement strategy, physician workload, treatment administration, outpatient procedures, and aftercare
- Possible multi-stakeholder pathways: Explore routes for development, approval, and commercialization of cell and gene therapies in larger patient groups